Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like Tiny New York Biotech With Ties To Massachusetts, Syntimmune, Gets A $50 Million Boost June 20, 2017 Bristol-Myers Who? Why a Marriage Between Pfizer and Biogen Makes More Sense November 13, 2017 Nestle Emerges as the Frontrunner for Merck KGaA's $5B Consumer Health Biz January 9, 2018
